Digital treatment map for ALK- and ROS1-mutated NSCLC
EVALUATION Thank you for your feedback! × Dismiss this alert. Welcome to our Digital Treatment Map A practical, expert-led, and evidence-based resource designed to help you navigate the different treatment lines of ALK and ROS1 mutation positive NSCLC. Join Dr Barbara Melosky, Dr Solange Peters, and Dr Ross Camidge as they guide you through this […]
Urothelial Cancer
Home Case studies Expert interviews eLearning News Expert challenge Portuguese Translation Treatment options for metastatic urothelial carcinoma Program launch date: November 2020Urothelial carcinoma is one of the most common malignancies worldwide. This innovative program comprises a suite of educational resources for those managing patients with metastatic urothelial carcinoma (mUC), having a particular focus on the […]
Enriched treatment pathway for type 2 diabetes
Welcome to our Enriched Treatment Pathway – an expert-led practical and evidence-based tool designed help you to provide optimal management of type 2 diabetes with glucagon-like peptide-1 receptor agonists (GLP-1RAs). You have immediate access to expert opinion and the latest data and evidence, with practical guidance on how to incorporate learning and knowledge into your […]
Treating Metastatic Renal Cell Carcinoma
Treating metastatic renal cell carcinoma: Patient case studies Program launch date: 16th November 2020The development of several targeted treatment options has revolutionized the treatment of metastatic RCC. Dr Axel Merseburger invites you to participate in this three-part case study series which looks at how to manage metastatic renal cell carcinoma (RCC). In the first case study, […]
Pathway tool
Program launch date: 13th March 2020 Access our new interactive and instructional tool, designed to help you navigate the different treatment lines of non-driver NSCLC. It is targeted at international (medical and radiation) oncologists and any other healthcare professionals involved in the diagnosis, treatment, and follow-up of patients with lung cancer. Select your region: North […]
MMPAD
A message from the Programme Director… With diagnoses of type 1 diabetes in Europe on the rise, healthcare professionals face increasing challenges in the prevention and management of paediatric diabetes as well as keeping on top of the latest research. In partnership with Springer Healthcare IME, I am delighted to present this European-wide set of […]
Targeting improved outcomes in EGFR-mutated NSCLC
Webcast Discussion and guidance on the characterization of EGFR mutation-positive tumor subtypes, appropriate sequencing of treatment and management of EGFR TKI resistance. Pathway Follow a patient’s progression using this interactive pathway as we support your clinical treatment decision-making supported by trial data and expert opinion. An expert-driven program addressing the optimal treatment strategy for patients […]
